★ Reviews ★

Let customers speak for us

750 reviews

Excellent flavor. Ordered with boost. Always love rasta vapes

The most delicious

It's been two years since I've known this juice, but I can't help but smoke it every day.

Really delicious

Great stuff

Grape ape

Ordered with flavor boost and wow. Excellent flavor. I have used rasta vapes before and i wish i would have found them sooner. Thank you rasta vapes for excellent juice. Best i had hands down

All day yummy !!!

Best juice ever !! I have been actually using it for years . I stepped away for a bit due to having to wait on shipping but I am back . Missed this yummy juice .

Dirty little secrets: Obamacare, GlaxoSmithKline and the FDA e-cig Regulations

When President Obama first began marketing Obamacare to the American People, the bill originally included specific language that would place very severe restrictions on Big Pharma’s ability to charge consumers extremely high prices for prescription medications. But as the bill struggled along in an attempt to gain enough congressional support to be signed into law, this language was deleted in late 2009. Almost immediately, the bill passed.

At almost the very same time, another piece of legislation was also making its way through the Halls of Congress. It was called the Tobacco Control Act and is the very basis for the newly announced FDA e-cig regulations that threaten to eradicate the entire vaping and electronic cigarette industry within the next two years. Coincidence? Keep reading.

FDA Mitch Zeller: Secret history with Big Pharma

Once the Tobacco Control Act became law, Obama now had to appoint someone to oversee a new branch of the FDA that was created as a result. He chose a man named Mitch Zeller to manage the newly formed Center for Tobacco Products.

Who is Mitch Zeller? His previous job was as a political lobbyist for the Big Pharma company GlaxoSmithKline, the very same company that currently has a case pending in front of the U.S. Supreme Court regarding allegations of intentionally falsifying information on the diabetes medication Avandia. Coincidentally, GlaxoSmithKline also holds the patent for the prescription-only Nicorette Gum, perhaps the most profitable smoking cessation product of all time. That is, until e-cigs and vaping devices came into the picture.

FDA e-cig regulations benefit Big Pharma

As the acting director of the Center for Tobacco Products, Mitch Zeller was the driving force behind the creation and implementation of the newly announced FDA e-cig regulations. Contained in the legal jargon is a phrase that sent shockwaves throughout the vaping community.

“The deeming regulation allows the FDA to regulate any product that is made or derived from tobacco that is intended for human consumption. This includes cigars, e-cigarettes, hookah, pipe tobacco, dissolvable tobacco products, and any other product containing tobacco, or nicotine derived from tobacco.”

As of May 5, 2016, e-cigs and vaping devices would now fall under the very same restrictions as Big Tobacco. As a result, retailers and manufacturers would also be required to undergo the already established Premarket Tobacco Application (PMTA) process which costs approximately $1 million per product. Furthermore, only one PMTA application has been approved in the past six years. By passing the FDA e-cig regulations, the partnership of Obamacare, Big Pharma, and the FDA’s Mitch Zeller may have singlehandedly wiped out the competition of GlaxoSmithKline’s Nicorette Gum overnight.